Novel nastorazepide-based radioligands demonstrate effective cholecystokinin-2 receptor targeting with potential for theranostic applications

Theranostics · Published 2026-07-29 · DOI 10.7150/thno.129327

Free full text

Authors (9)

Lennart Bohrmann, Doroteja Novak, Marko Kroselj, Raghuvir H. Gaonkar, Francesca Porto, Melpomeni Fani, Petra Kolenc, Marko Anderluh, Rosalba Mansi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Bohrmann, L., Novak, D., Kroselj, M., et al. (2026). Novel nastorazepide-based radioligands demonstrate effective cholecystokinin-2 receptor targeting with potential for theranostic applications. Theranostics. https://doi.org/10.7150/thno.129327

Related articles

• Epigenetic subtypes of high-grade T1 bladder cancer reveal intra-tumor heterogeneity and distinct interactions with tumor microenvironment · Theranostics · 2026 · Same journal
• Surface-cleaned black phosphorus nanosheets chelate iron and rebalance the ferroptosis-immune axis in acute kidney injury · Theranostics · 2026 · Same journal
• Understanding immune checkpoint inhibitors-related myocarditis: Mechanisms and targeted therapeutic pathways · Theranostics · 2026 · Same journal
• Inhibition of SRC prevents bone metastasis of breast cancer by blocking metastatic cell motility and bone directionality · Theranostics · 2026 · Same journal
• Magnetic hyperthermia as an intracellular immunomodulatory technology: From heat transduction to tumor immune reprogramming · Theranostics · 2026 · Same journal
• Ultra-high-field magnetic resonance imaging reveals sex-specific recovery after ischemic stroke following treatment with three-dimensional human mesenchymal stem cell–derived extracellular vesicles · Theranostics · 2026 · Same journal
• Targeting microglial MyD88 reprograms injury-activated microglia and promotes spinal cord repair via TGF-β signaling and biomimetic nanodelivery · Theranostics · 2026 · Same journal
• miR-15a-5p outperforms anti-VEGF drug in ocular neovascularization by providing dual anti-angiogenic and neuroprotective effects · Theranostics · 2026 · Same journal
• Recent advances in targeting cyanine dyes: hierarchical targeting mechanisms and theranostic integration for multi-disease precision therapy · Theranostics · 2026 · Same journal
• NOD1 is a key mediator of atrial myopathy in heart failure · Theranostics · 2026 · Same journal